Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Toxicologic Pathology
|
December 12, 2024
IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research
Thomas Steger-Hartmann, Ferran Sanz, Frank Bringezu, et al.
ALTEX
|
May 29, 2024
The road to virtual control groups and the importance of proper body-weight selection
Alexander Gurjanov, Lea A I Vaas, Thomas Steger-Hartmann
Chemical Research in Toxicology
|
April 20, 2025
Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets
Aljoša Smajić, Thomas Steger-Hartmann, Gerhard F Ecker, et al.
Chemosphere
|
November 21, 2009
Discussion by Reinhard Länge et al. on "Degradation of the endocrine disrupting chemicals (EDCs) carbamazepine, clofibric acid, and iopromide by corona discharge over water" by Krause et al. [Chemosphere 75(2) (2009) 163-168]
Reinhard Länge, Thomas Steger-Hartmann, Steffen A Borden, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
November 26, 2009
Gadolinium-based contrast agents and NSF: evidence from animal experience
Martin A Sieber, Thomas Steger-Hartmann, Philipp Lengsfeld, et al.
Investigative Radiology
|
April 21, 2006
Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography
Thomas Steger-Hartmann, Philip B Graham, Simone Müller, et al.
Toxicology Reports
|
October 1, 2017
Value of shared preclinical safety studies - The eTOX database
Katharine Briggs, Chris Barber, Montserrat Cases, et al.
Water Research
|
January 5, 2002
Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium
Thomas Steger-Hartmann, Reinhard Länge, Hermann Schweinfurth, et al.
Frontiers in Pharmacology
|
August 21, 2023
Editorial: Advances in and applications of predictive toxicology: 2022
Abdulkarim Najjar, Nynke Kramer, Iain Gardner, et al.
ALTEX
|
April 30, 2025
Virtual control groups in non-clinical toxicology - A replicability challenge
Thomas Steger-Hartmann, Guillemette Duchateau-Nguyen, Frank Bringezu, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Toxicologic Pathology
|
December 12, 2024
IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research
Thomas Steger-Hartmann, Ferran Sanz, Frank Bringezu, et al.
ALTEX
|
May 29, 2024
The road to virtual control groups and the importance of proper body-weight selection
Alexander Gurjanov, Lea A I Vaas, Thomas Steger-Hartmann
Chemical Research in Toxicology
|
April 20, 2025
Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets
Aljoša Smajić, Thomas Steger-Hartmann, Gerhard F Ecker, et al.
Chemosphere
|
November 21, 2009
Discussion by Reinhard Länge et al. on "Degradation of the endocrine disrupting chemicals (EDCs) carbamazepine, clofibric acid, and iopromide by corona discharge over water" by Krause et al. [Chemosphere 75(2) (2009) 163-168]
Reinhard Länge, Thomas Steger-Hartmann, Steffen A Borden, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
November 26, 2009
Gadolinium-based contrast agents and NSF: evidence from animal experience
Martin A Sieber, Thomas Steger-Hartmann, Philipp Lengsfeld, et al.
Investigative Radiology
|
April 21, 2006
Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography
Thomas Steger-Hartmann, Philip B Graham, Simone Müller, et al.
Toxicology Reports
|
October 1, 2017
Value of shared preclinical safety studies - The eTOX database
Katharine Briggs, Chris Barber, Montserrat Cases, et al.
Water Research
|
January 5, 2002
Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium
Thomas Steger-Hartmann, Reinhard Länge, Hermann Schweinfurth, et al.
Frontiers in Pharmacology
|
August 21, 2023
Editorial: Advances in and applications of predictive toxicology: 2022
Abdulkarim Najjar, Nynke Kramer, Iain Gardner, et al.
ALTEX
|
April 30, 2025
Virtual control groups in non-clinical toxicology - A replicability challenge
Thomas Steger-Hartmann, Guillemette Duchateau-Nguyen, Frank Bringezu, et al.
Page
of 7